Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Definitive Healthcare (DH) Cash from Financing Activities (2020 - 2025)

Historic Cash from Financing Activities for Definitive Healthcare (DH) over the last 6 years, with Q3 2025 value amounting to -$12.5 million.

  • Definitive Healthcare's Cash from Financing Activities fell 336.51% to -$12.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$160.2 million, marking a year-over-year decrease of 22410.05%. This contributed to the annual value of -$56.7 million for FY2024, which is 12181.44% down from last year.
  • Latest data reveals that Definitive Healthcare reported Cash from Financing Activities of -$12.5 million as of Q3 2025, which was down 336.51% from -$24.7 million recorded in Q2 2025.
  • Over the past 5 years, Definitive Healthcare's Cash from Financing Activities peaked at $234.7 million during Q4 2021, and registered a low of -$109.7 million during Q1 2025.
  • Its 5-year average for Cash from Financing Activities is $6.8 million, with a median of -$6.7 million in 2022.
  • Per our database at Business Quant, Definitive Healthcare's Cash from Financing Activities soared by 830262.15% in 2021 and then plummeted by 53804.82% in 2025.
  • Definitive Healthcare's Cash from Financing Activities (Quarter) stood at $234.7 million in 2021, then crashed by 104.03% to -$9.5 million in 2022, then skyrocketed by 35.9% to -$6.1 million in 2023, then plummeted by 120.52% to -$13.4 million in 2024, then increased by 6.71% to -$12.5 million in 2025.
  • Its Cash from Financing Activities was -$12.5 million in Q3 2025, compared to -$24.7 million in Q2 2025 and -$109.7 million in Q1 2025.